相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis
Mark M. Fuster et al.
JOURNAL OF CELL BIOLOGY (2007)
Protein-losing enteropathy after Fontan operation: Investigations into possible pathophysiologic mechanisms
Adam M. Ostrow et al.
ANNALS OF THORACIC SURGERY (2006)
Applied glycoproteomics - approaches to study genetic-environmental collisions causing protein-losing enteropathy
L Bode et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2006)
Heparan sulfate plays a central role in a dynamic in vitro model of protein-losing enteropathy
L Bode et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Mechanism of nitric oxide-mediated intestinal barrier failure: insight into the pathogenesis of necrotizing enterocolitis
HR Ford
JOURNAL OF PEDIATRIC SURGERY (2006)
Mice deficient in Ext2 lack heparan sulfate and develop exostoses
D Stickens et al.
DEVELOPMENT (2005)
Epithelial barrier function in vivo is sustained despite gaps in epithelial layers
AJM Watson et al.
GASTROENTEROLOGY (2005)
In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis
JP Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Heparan sulfate depletion amplifies TNF-α-induced protein leakage in an in vitro model of protein-losing enteropathy
L Bode et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior
E Zcharia et al.
FASEB JOURNAL (2004)
Mammalian brain morphogenesis and midline axon guidance require heparan sulfate
M Inatani et al.
SCIENCE (2003)
Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration
K Endo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Enhanced production of interferon-gamma as a possible cause of protein-losing enteropathy after modified Fontan operation
T Shimizu et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2003)
Protein-losing enteropathy in patients with Fontan circulation:: is it triggered by infection?
D Lenz et al.
CRITICAL CARE (2003)
Fecal alpha(1)-antitrypsin concentrations as a measure of enteric protein loss after modified Fontan operations
T Fujii et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2003)
Outcomes after the Fontan procedure
BS Marino
CURRENT OPINION IN PEDIATRICS (2002)
cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine
BB Madison et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Oral mannose therapy persistently corrects the severe clinical symptoms and biochemical abnormalities of phosphomannose isomerase deficiency
HK Harms et al.
ACTA PAEDIATRICA (2002)
Protein-losing enteropathy
I Bendayan et al.
PEDIATRIC CARDIOLOGY (2002)
Effects of AT1 receptor antagonist on proteoglycan gene expression in hypertensive rats
H Sasamura et al.
HYPERTENSION RESEARCH (2001)
Reduced heparan sulfate accumulation in enterocytes contributes to protein-losing enteropathy in a congenital disorder of glycosylation
V Westphal et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice
X Lin et al.
DEVELOPMENTAL BIOLOGY (2000)
Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice
CM Alexander et al.
NATURE GENETICS (2000)
Heparin therapy and reversal of protein-losing enteropathy in a case with congenital heart disease
I Bendayán et al.
PEDIATRIC CARDIOLOGY (2000)
分享论文
